Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
New AI blood test tracks pancreatic cancer treatment response

New AI blood test tracks pancreatic cancer treatment response

New technique rapidly tracks cell state changes through density measurements

New technique rapidly tracks cell state changes through density measurements

Precision nano therapy targets tumor nerves in pancreatic cancer

Precision nano therapy targets tumor nerves in pancreatic cancer

New immunotherapy target found in pancreatic cancer cells

New immunotherapy target found in pancreatic cancer cells

ZIP4 protein identified as driver of glioblastoma aggression

ZIP4 protein identified as driver of glioblastoma aggression

HonorHealth unveils first study from new Phoenix lab targeting pancreatic cancer

HonorHealth unveils first study from new Phoenix lab targeting pancreatic cancer

Predictive model could improve treatment decisions for advanced pancreatic cancer patients

Predictive model could improve treatment decisions for advanced pancreatic cancer patients

MD Anderson researchers present promising clinical trial results at AACR 2025

MD Anderson researchers present promising clinical trial results at AACR 2025

Transitioning pancreatic cells show lasting epigenetic cancer traits

Transitioning pancreatic cells show lasting epigenetic cancer traits

New connective tissue cells could open path to pancreatic cancer treatment

New connective tissue cells could open path to pancreatic cancer treatment

Expansion of mutant blood cells linked to worse cancer outcomes

Expansion of mutant blood cells linked to worse cancer outcomes

DNA origami structures enable targeted imaging of pancreatic cancer

DNA origami structures enable targeted imaging of pancreatic cancer

AGA announces $2.4 million in research funding for 74 recipients

AGA announces $2.4 million in research funding for 74 recipients

GOT2 as a metabolic and immunologic target in pancreatic cancer

GOT2 as a metabolic and immunologic target in pancreatic cancer

Study identifies a new key factor contributing to aggressive nature of pancreatic cancer

Study identifies a new key factor contributing to aggressive nature of pancreatic cancer

Inherited mutations in healthy cells may contribute to cancer development

Inherited mutations in healthy cells may contribute to cancer development

New method uses sugar molecules to identify pancreatic cancer subtypes

New method uses sugar molecules to identify pancreatic cancer subtypes

New molecular target identified for pancreatic cancer treatment

New molecular target identified for pancreatic cancer treatment

Pancreatic cells show epigenetic marks before cancerous transformation

Pancreatic cells show epigenetic marks before cancerous transformation

Study sheds light on how major cancer gene influences the success of PARP inhibitors

Study sheds light on how major cancer gene influences the success of PARP inhibitors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.